Dr Xylina T Gregg, MD in Salt Lake City, UT - Medicare Medical Oncology

Dr Xylina T Gregg, MD is a medicare enrolled "Internal Medicine - Medical Oncology" physician in Salt Lake City, Utah. She went to Baylor College Of Medicine and graduated in 1991 and has 33 years of diverse experience with area of expertise as Medical Oncology. She is a member of the group practice Utah Cancer Specialists Pc and her current practice location is 3838 S 700 E, Suite 100, Salt Lake City, Utah. You can reach out to her office (for appointments etc.) via phone at (801) 269-0231.

Dr Xylina T Gregg is licensed to practice in Utah (license number 6011093-1205) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1972554459.

Contact Information

	Dr Xylina T Gregg, MD
	3838 S 700 E, Suite 100, Salt Lake City, UT 84106-1466
	(801) 269-0231
	(801) 269-0304

Physician's Profile

Full Name	Dr Xylina T Gregg
Gender	Female
Speciality	Medical Oncology
Experience	33 Years
Location	3838 S 700 E, Salt Lake City, Utah
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Xylina T Gregg attended and graduated from Baylor College Of Medicine in 1991

NPI Data:

NPI Number: 1972554459
Provider Enumeration Date: 05/12/2006
Last Update Date: 10/10/2016

Medicare PECOS Information:

PECOS PAC ID: 4183606189
Enrollment ID: I20051222000283

Medical Identifiers

Medical identifiers for Dr Xylina T Gregg such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1972554459	NPI	-	NPPES
107043717101	Other	UT	SELECT HEALTH
P00297844	Other	UT	RAILROAD MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	6011093-1205 (Utah)	Secondary
207RX0202X	Internal Medicine - Medical Oncology	6011093-1205 (Utah)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Intermountain Medical Center	Murray, UT	Hospital
St Mark's Hospital	Salt lake city, UT	Hospital
Lone Peak Hospital	Draper, UT	Hospital
Lds Hospital	Salt lake city, UT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Utah Cancer Specialists Pc	1355254749	39

News Archive

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in Canada to Cipher Pharmaceuticals Inc.

Scientists develop highly efficient approach for cardiac imaging

Scientists of the Charité - Universitätsmedizin Berlin and the Max-Delbrück-Center for Molecular Medicine Berlin-Buch have developed a highly efficient approach for imaging the beating human heart.

Glissandra Skincare launches three signature anti-aging products

Glissandra™ Skincare Inc. announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund's "Women of Action" awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.

Eisai acquires AkaRx for approximately $255 million

Eisai Inc. (Headquarters: Woodcliff Lake, New Jersey, Chairman and CEO: Hajime Shimizu, "Eisai") today announces the successful completion of its acquisition of the biopharmaceutical company, AkaRx, Inc. (Headquarters: Bridgewater, New Jersey, CEO: Robert E. Desjardins), for approximately $255 million.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Xylina T Gregg allows following entities to bill medicare on her behalf.

Entity Name	Utah Cancer Specialists Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1619925369 PECOS PAC ID: 1355254749 Enrollment ID: O20031111000618

News Archive

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in Canada to Cipher Pharmaceuticals Inc.

Scientists develop highly efficient approach for cardiac imaging

Glissandra Skincare launches three signature anti-aging products

Eisai acquires AkaRx for approximately $255 million

Entity Name	University Of Utah Adult Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in Canada to Cipher Pharmaceuticals Inc.

Scientists develop highly efficient approach for cardiac imaging

Glissandra Skincare launches three signature anti-aging products

Eisai acquires AkaRx for approximately $255 million

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Xylina T Gregg is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Xylina T Gregg, MD 1121 E 3900 S, Suite C-240, Salt Lake City, UT 84124-1214 Ph: (801) 266-0878	Dr Xylina T Gregg, MD 3838 S 700 E, Suite 100, Salt Lake City, UT 84106-1466 Ph: (801) 269-0231

News Archive

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in Canada to Cipher Pharmaceuticals Inc.

Scientists develop highly efficient approach for cardiac imaging

Glissandra Skincare launches three signature anti-aging products

Eisai acquires AkaRx for approximately $255 million

Internal Medicine Doctors in Salt Lake City, UT

Dr. Mehmet Akkaya, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689
Dr. Willard Dere, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565
Megan Meier, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121
Joel Money, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121
Mchale O. Anderson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451
Siddharth K. Iyengar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606
Taryn A. Young, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398

Dr Xylina T Gregg, MD - Medicare Medical Oncology in Salt Lake City, UT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Scientists develop highly efficient approach for cardiac imaging

Glissandra Skincare launches three signature anti-aging products

Eisai acquires AkaRx for approximately $255 million

Medicare Reassignments

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Scientists develop highly efficient approach for cardiac imaging

Glissandra Skincare launches three signature anti-aging products

Eisai acquires AkaRx for approximately $255 million

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Scientists develop highly efficient approach for cardiac imaging

Glissandra Skincare launches three signature anti-aging products

Eisai acquires AkaRx for approximately $255 million

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Scientists develop highly efficient approach for cardiac imaging

Glissandra Skincare launches three signature anti-aging products

Eisai acquires AkaRx for approximately $255 million

Internal Medicine Doctors in Salt Lake City, UT